Tempus AI (NASDAQ:TEM) Shares Gap Up – What’s Next?

Tempus AI, Inc. (NASDAQ:TEM)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $61.85, but opened at $64.30. Tempus AI shares last traded at $67.59, with a volume of 5,013,447 shares traded.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Needham & Company LLC restated a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a research note on Tuesday, January 14th. TD Cowen reaffirmed a “buy” rating and set a $74.00 target price (up from $58.00) on shares of Tempus AI in a research report on Wednesday. Loop Capital decreased their price objective on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday, January 14th. Wolfe Research assumed coverage on Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective on the stock. Finally, Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and lifted their target price for the company from $45.00 to $65.00 in a report on Monday, November 11th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Tempus AI presently has a consensus rating of “Moderate Buy” and a consensus price target of $58.55.

Tempus AI Price Performance

The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The stock has a 50 day moving average price of $44.36 and a 200 day moving average price of $48.84.

Insider Buying and Selling

In other Tempus AI news, EVP Andrew Polovin sold 51,504 shares of the business’s stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the completion of the sale, the executive vice president now directly owns 246,085 shares in the company, valued at $10,431,543.15. The trade was a 17.31 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the sale, the insider now directly owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. This represents a 2.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,058,072 shares of company stock worth $90,719,375 in the last three months.

Institutional Trading of Tempus AI

Hedge funds have recently bought and sold shares of the stock. First Horizon Advisors Inc. bought a new position in Tempus AI in the 3rd quarter valued at $30,000. FNY Investment Advisers LLC purchased a new position in shares of Tempus AI in the fourth quarter worth about $67,000. IFP Advisors Inc acquired a new stake in shares of Tempus AI during the fourth quarter worth about $76,000. US Bancorp DE acquired a new position in Tempus AI in the 4th quarter worth approximately $80,000. Finally, Vestor Capital LLC acquired a new stake in Tempus AI during the 3rd quarter valued at approximately $153,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.